Cargando…

The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer

BACKGROUND: Circulating tumor DNA (ctDNA) is a kind of cell-free DNA which comes from tumor cells and effectively reflects the molecular characteristics of tumors, which providing us a novel method to explore its clinical therapeutic value in advanced lung cancer. METHODS: A total of 36 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiao, Dong, Wentao, Lai, Xiaojing, Feng, Wei, Yu, Xiaofu, Gu, Qing, Wang, Chunyang, Xiao, Wen, Zheng, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797680/ https://www.ncbi.nlm.nih.gov/pubmed/35116746 http://dx.doi.org/10.21037/tcr.2019.01.20

Ejemplares similares

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
por: Yao, Yu, et al.
Publicado: (2016)

Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017)

Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
por: Fernandez-Cuesta, Lynnette, et al.
Publicado: (2016)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer
por: Yin, Jian-xin, et al.
Publicado: (2021)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

Efficacy and safety evaluation of neoadjuvant immunotherapy plus chemotherapy for resectable non–small cell lung cancer in real world
por: Fang, Min, et al.
Publicado: (2023)

Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA
por: Yaung, Stephanie J., et al.
Publicado: (2022)

The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021)

Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
por: Fan, Gaowei, et al.
Publicado: (2017)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
por: Fang, Xiaoxu, et al.
Publicado: (2022)

Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients
por: Wang, Zhen, et al.
Publicado: (2023)

Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer
por: Cheng, Lei, et al.
Publicado: (2023)

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
por: Xu, Ruilian, et al.
Publicado: (2018)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

Clinical value of peripheral blood circulating tumor DNA in predicting the efficacy of immunotherapy for non-small cell lung cancer
por: Wang, Jing, et al.
Publicado: (2023)

Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease
por: Wei, Zhangjing, et al.
Publicado: (2016)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma
por: Liu, Xiang-Liang, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Circulating tumor DNA detection in lung cancer patients before and after surgery
por: Guo, Nannan, et al.
Publicado: (2016)

Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
por: Chen, Ke-Zhong, et al.
Publicado: (2016)

CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
por: Peng, Hao, et al.
Publicado: (2019)

An enzymatic on/off switch‐mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA
por: Wang, Qing‐lin, et al.
Publicado: (2020)

The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer
por: Lyu, Mengyuan, et al.
Publicado: (2019)

Detection of circulating tumor DNA for advanced bladder cancer: where are we going?
por: Morales-Barrera, Rafael, et al.
Publicado: (2018)

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
por: Duan, Guo-Chen, et al.
Publicado: (2020)

Detection of circulating tumor DNA from non‐small cell lung cancer brain metastasis in cerebrospinal fluid samples
por: Ma, Chunhua, et al.
Publicado: (2020)

Combined use of circulating tumor cells and salivary mRNA to detect non–small-cell lung cancer
por: Gu, Xianwen, et al.
Publicado: (2020)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer
por: Visser, Esther, et al.
Publicado: (2022)

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment
por: Sueoka‐Aragane, Naoko, et al.
Publicado: (2021)

Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer
por: Andrikou, Kalliopi, et al.
Publicado: (2023)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients
por: Ryu, Woo Kyung, et al.
Publicado: (2022)

Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation
por: Wang, Zhoufeng, et al.
Publicado: (2023)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer
por: Wen, Sara Witting Christensen, et al.
Publicado: (2021)

Next-generation sequencing of circulating tumor DNA for detection of gene mutations in lung cancer: implications for precision treatment
por: Lai, Jinhuo, et al.
Publicado: (2018)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e5vtc632g9ocbmho7rvagifc9l